- Investing Ideas
- Global Pharmaceuticals & Biotech Spotless Management
Global Pharmaceuticals & Biotech Spotless Management
Results
7
Well rounded companies, with acceptable leverage, projected to deliver an ROE north of 20% in three years.
7 companies
AstraZeneca
Market Cap: UK£214.9b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN
UK£145.38
7D
3.4%
1Y
42.5%
Gilead Sciences
Market Cap: US$156.9b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILD
US$125.97
7D
0.6%
1Y
13.0%
Chugai Pharmaceutical
Market Cap: JP¥12.2t
Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.
4519
JP¥7,420.00
7D
-1.5%
1Y
5.5%
Orion Oyj
Market Cap: €10.0b
Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.
ORNBV
€72.15
7D
2.7%
1Y
16.2%
Shanghai Allist Pharmaceuticals
Market Cap: CN¥58.9b
A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China in internationally.
688578
CN¥130.87
7D
37.6%
1Y
38.3%
Xiamen Amoytop Biotech
Market Cap: CN¥23.5b
Engages in research, development, production, and sale of recombinant protein drugs in China and internationally.
688278
CN¥57.46
7D
6.1%
1Y
-20.5%
PharmaResearch
Market Cap: ₩3.7t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩360,500.00
7D
11.8%
1Y
-27.8%